Document ID: chunk:federal_register_of_legislation:F2025L00149:front:0:p4
Version: federal_register_of_legislation:F2025L00149
Segment Type: other
Provision Reference: 
Character Range: 8657–11822

sitting, 3-4 METs = cardiorespiratory effort associated with a person walking at average walking pace (5 km/h) or light gardening.
 1.       being sedentary for a cumulative total of at least 10 hours per day on more days than not for at least the 5 years before clinical onset or clinical worsening;
Note: being sedentary is defined in the Schedule 1 - Dictionary.
 1.       an inability to consume an average of at least 100 grams per day of vegetables or fruits, for at least the 5 years before clinical onset or clinical worsening;
 2.       having chronic kidney disease before clinical onset or clinical worsening as indicated by one of the following:
         1.           a glomerular filtration rate of less than 60 mL/min/1.73 m2 for at least 3 months;
         2.           albuminuria with an albumin to creatinine ratio of at least 3 milligrams/millimole for at least 3 months;
         3.           kidney damage, as evidenced by renal biopsy, imaging studies, urinary sediment abnormalities or other markers of abnormal renal function;
         4.           having had a kidney transplant;
 3.       having hypothyroidism for at least 2 years within the 10 years before clinical onset or clinical worsening;
Note: Hashimoto thyroiditis can cause hypothyroidism.
 1.       having Hashimoto thyroiditis for at least 2 years within the 10 years before clinical onset or clinical worsening;
 2.       having received a cumulative equivalent dose of at least 0.5 sievert of ionising radiation to the heart at least 1 year before clinical onset or clinical worsening;
Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
 1.       having radiotherapy for cancer, where the heart was in the field of radiation, before clinical onset or clinical worsening;
 2.       inhaling, ingesting or having cutaneous contact with 1,2 propylene glycol dinitrate (Otto fuel II):
         1.           for a cumulative period of at least 1,000 hours within a consecutive period of 10 years, before clinical onset or clinical worsening; and
         2.           where the first exposure occurred at least 5 years before clinical onset or clinical worsening;
and if that exposure has ceased before clinical onset or clinical worsening, then that onset or worsening occurred within 25 years of cessation;
 1.       undergoing a procedure involving catheterisation of the affected coronary artery within the 30 days before clinical onset or clinical worsening of myocardial infarction or unstable angina;
 2.       having infective endocarditis at the time of the clinical onset of myocardial infarction;
 3.       having syphilis involving the coronary arteries at the time of clinical onset or clinical worsening;
 4.       having one of the following vasculitides at the time of clinical onset or clinical worsening:
         1.           antineutrophilic cytoplasmic antibody (ANCA) associated vasculitis;
         2.           Behcet disease;
         3.           eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome);
         4.           giant cell (temporal) arteritis;
         5.           granulomatosis with polyangiitis